Literature DB >> 9257720

MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells.

H M Kim1, G T Oh, D H Hong, M S Kim, J S Kang, S M Park, S B Han.   

Abstract

The relevance of MDR-1 gene expression to the multidrug resistance phenotype was investigated. Drug-resistant cells, KB-V1 and MCF7/ADR, constantly expressed mRNA of the MDR-1 gene and were more resistant to vinblastine and adriamycin than drug-sensitive cells, KB-3-1 and MCF7. The drug efflux rate of KB-V1 was the same as KB-3-1 although the MDR-1 gene was expressed in only the resistant cell. The higher intracellular drug concentration of KB-3-1 than KB-V1 was due to the large drug influx. In the case of MCF7 and MCF7/ADR, the influx and efflux of the drug had nearly the same pattern and drug efflux was not affected by verapamil. The amount of ATP, cofactor of drug pumping activity of P-glycoprotein, was not changed by the resistance. These observations suggested that drug efflux mediated by MDR-1 gene expression was not a major determining factor of drug resistance in the present cell systems, and that the drug resistance could be derived from the change in drug uptake and other mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257720     DOI: 10.1016/s0014-5793(97)00777-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Pseudolaric acid B-driven phosphorylation of c-Jun impairs its role in stabilizing HIF-1alpha: a novel function-converter model.

Authors:  Bing Yu; Mei-Hong Li; Wei Wang; Ying-Qing Wang; Yi Jiang; Sheng-Ping Yang; Jian-Min Yue; Jian Ding; Ze-Hong Miao
Journal:  J Mol Med (Berl)       Date:  2012-03-10       Impact factor: 4.599

2.  Anticancer activity of a novel small molecule tubulin inhibitor STK899704.

Authors:  Krisada Sakchaisri; Sun-Ok Kim; Joonsung Hwang; Nak Kyun Soung; Kyung Ho Lee; Tae Woong Choi; Yongjun Lee; Chan-Mi Park; Naraganahalli R Thimmegowda; Phil Young Lee; Bettaswamigowda Shwetha; Ganipisetti Srinivasrao; Thi Thu Huong Pham; Jae-Hyuk Jang; Hye-Won Yum; Young-Joon Surh; Kyung S Lee; Hwangseo Park; Seung Jun Kim; Yong Tae Kwon; Jong Seog Ahn; Bo Yeon Kim
Journal:  PLoS One       Date:  2017-03-15       Impact factor: 3.240

3.  CPPF, A Novel Microtubule Targeting Anticancer Agent, Inhibits the Growth of a Wide Variety of Cancers.

Authors:  Ho Jin Han; Chanmi Park; Joonsung Hwang; Thimmegowda N R; Sun-Ok Kim; Junyeol Han; Minsik Woo; Shwetha B; In-Ja Ryoo; Kyung Ho Lee; Hyunjoo Cha-Molstad; Yong Tae Kwon; Bo Yeon Kim; Nak-Kyun Soung
Journal:  Int J Mol Sci       Date:  2020-07-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.